Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany · Delayed Price · Currency is EUR 0.0010
0.00 (0.00%)
At close: Dec 19, 2025
FRA:9RP Market Cap
FRA:9RP has a market cap or net worth of €446 thousand as of December 22, 2025. Its market cap has decreased by -79.54% in one year.
Market Cap
446.00K
Enterprise Value
-1.08M
Revenue
119.12K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since March 1, 2021, FRA:9RP's market cap has decreased from 9.62M to 446.00K, a decrease of -95.36%. That is a compound annual growth rate of -47.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 446.00K | -70.14% |
| Dec 30, 2024 | 1.49M | -69.44% |
| Dec 29, 2023 | 4.89M | 240.47% |
| Dec 30, 2022 | 1.44M | -76.76% |
| Dec 30, 2021 | 6.18M | -35.79% |
| Mar 1, 2021 | 9.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |